Concepedia
Statistics
Publications
5
Citations
1K
H-Index
Active since
2018
Affiliations
University of Basel(Current)
University of Bern
University Hospital of Basel
Landesklinikum Korneuburg
Lutz Achtnichts is an author at University of Basel specializing in multiple sclerosis, life sciences, and immunology.
Publications per year
2018–2025
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations
Medicine, Neurology, Pharmacology +9
Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis
Lutz Achtnichts, Barbara Jakopp, Michael Oberle et al. · Vaccines · 2021 · 46 citations · Full text
Life Sciences, Immunology, Autoimmunity +16
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis
Johanna Oechtering, Kerstin Stein, Sabine Schaedelin et al. · Neurology Neuroimmunology & Neuroinflammation · 2024 · 33 citations · Full text
Life Sciences, Immunology, Neurology +17
SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot
Lutz Achtnichts, Barbara Jakopp, Michael Oberle et al. · Vaccines · 2022 · 13 citations · Full text
Life Sciences, Immunology, Immunization +16
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis
Johanna Oechtering, Sabine Schädelin, Kerstin Stein et al. · Neurology Neuroimmunology & Neuroinflammation · 2025 · 12 citations · Full text
Life Sciences, Neurology, Neuroscience +17
1–5 of 5